Ameliorative effects of half-dose saffron and chamomile combination on Psycho-endocrinological changes in a diabetic murine model

PLoS One. 2022 Oct 27;17(10):e0276236. doi: 10.1371/journal.pone.0276236. eCollection 2022.

Abstract

Introduction: Diabetes mellitus is a chronic metabolic disorder with an increasing prevalence worldwide. Reduction in blood insulin level alters brain function by inducing oxidative stress with changes in dopamine and norepinephrine neurotransmission, ultimately leading to neuropsychological symptoms. The efficacy of currently available psychotropic drugs is not satisfactory. Therefore, this study was conducted to explore the beneficial effects of a combination of the natural herbs, saffron and chamomile, in treating diabetes and its resultant neuropsychological effects using a rodent model of diabetes mellitus.

Method: The rats were randomly divided in to eight groups (n = 10), healthy control (HC), diabetic control (DC) and six groups of diabetic rats treated with various concentrations and combinations of saffron and chamomile. Diabetic treatment groups individually received methanolic extract and water decoction of chamomile (30 mg/kg) and saffron (10mg/kg) and their combined half doses (saffron 5mg/kg and chamomile 15mg/kg) for two weeks. Open field test (OFT) and forced swim test (FST) were used to measure the anxiolytic and antidepressant effects of herbs, respectively. Finally, biochemical, and neurochemical estimations were made.

Results: The present study suggests the therapeutic effects of herbs especially in co-administrated decoction, against diabetes with improved antioxidant profile and enhanced levels of dopamine and norepinephrine. Anxiolytic and antidepressant effects were evident with improvements in the OFT and FST. Examination of the cortex of the diabetic group revealed cellular damage and tangle formation, which indicates advanced stages of dementia.

Conclusion: This study shows that the use of a combination of saffron and chamomile improves diabetes control and reduces its related psychiatric effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Anxiety Agents* / therapeutic use
  • Antidepressive Agents / therapeutic use
  • Chamomile
  • Crocus*
  • Diabetes Mellitus, Experimental* / metabolism
  • Disease Models, Animal
  • Dopamine / therapeutic use
  • Mice
  • Norepinephrine / therapeutic use
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Rats

Substances

  • Anti-Anxiety Agents
  • Dopamine
  • Plant Extracts
  • Antidepressive Agents
  • Norepinephrine

Grants and funding

This work was supported by the Dean’s Fund of Aga Khan University, Dr Saara Ahmad. Higher Education Commision, Pakistan, 9447, Dr Saara Ahmad.